Stocks in news: LIC, Granules, Siemens, CAMS, Hero MotoCorp, GAILGranules India announced that the USFDA has approved its Abbreviated New Drug Application, filed by Granules Pharmaceuticals, a wholly owne...
Lupin rallies 4% after multiple approvals from USFDAIn a regulatory filing, the company said it has received approval from the USFDA for mirabegron extended-release tablets.
View: Could the Oscar Go to...Pfizer?I was a little confused. Wasn't it the same as what was once called 'impotence'? I did not attach too much significance to the ED article t...
Market movers: Why did Lupin jump 4% & OMCs take a big hit due to electionsPharma stocks have been in demand given the rapid rise in dollar, which boosts the prospects of the export oriented companies. And, at such...
Drug eTailers face traditional pharma retailers’ wrath as policy evolvesFollowing the issuance of the draft guidelines by the government, stakeholders are expected to send their suggestions within a forty-five d...
Set to conquer US, Indian 'Viagras' may give Pfizer a hard timeThe nearing end of Pfizer's patent will open floodgates of the lucrative US market to Indian companies.
Aurobindo Pharma gets USFDA nod for generic of Pfizer's RevatioAurobindo Pharma received approval from the USFDA to manufacture and market generic version of Pfizer's Revatio tablets used in the treatme...
Viagra may prevent malaria transmissionThe anti-impotence drug Viagra helps eliminate malaria from the blood circulation which may reduce transmission of the deadly parasite from...
Aurobindo Pharma shares gain 6.5 per cent on USFDA nodThe scrip jumped 6.19 per cent to settle the day at Rs 1,324.95 on the BSE. In intra-day, it gained 6.59 per cent to Rs 1,330, its 52-week ...
Aurobindo Pharma gets USFDA nod for Sildenafil injectionUSFDA-approved Sildenafil injection, treats pulmonary arterial hypertension and is a generic version of Pfizer's Revatio injection.
In desi Viagra market, companies fight over namesSettling a trademark dispute between two major desi viagra players on Wednesday, the IPAB disallowed them from using two trademarks.
Dr Reddy's announces launch of Sildenafil tabletsThis followed the approval by the United States Food & Drug Administration of Dr Reddy's ANDA for Sildenafil tablets, a company statement s...
- Surya Pharma launches neuropsychiatric division
The Rs 1,600-crore Surya Pharmaceutical has launched its Super speciality Neuropsychiatric division called ALVIN .
- Ranbaxy fights NPPA's price control move
Ranbaxy and drugs price regulator National Pharmaceutical Pricing Authority (NPPA) have locked horns once again over the pricing of two key...
- Viagra sales go limp after flourish
Viagra and its numerous desi cousins have shown a minuscule growth of 5.43 per cent in sales. Fear of side-effects has hit sales
- Generics market may lose value on margin cut
The proposed trade margin cut on generic drugs from October 2 is set to be applicable to 2,000 brands of specified strengths, and as a resu...
- China pharma cos stand up against Viagra ruling
Twelve Chinese pharma companies are appealing a court ruling that sides with Pfizer and prevents local drugmakers from selling generic vers...